Not recruiting
Metabolic dysfunction-associated steatohepatitis
Not recruitingStudy on the Effects of Pemafibrate and Tofogliflozin in Patients with Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis
Investigational
Study on the Effects of Pemafibrate and Tofogliflozin in Patients with Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis
Investigational
- Disease:Metabolic dysfunction-associated steatohepatitis
- Substances:PemafibrateTofogliflozin
Countries:
Bulgaria
Bulgaria- Participants:18–64 years
- Substances:Pemafibrate

